An Analysis Of Amedisys Inc. (AMED)’s Weekly Performance


As of Wednesday close, Amedisys Inc.’s (NASDAQ:AMED) stock was up $3.78, moving up 4.32 percent to $91.25. The average number of shares traded per day over the past five days has been 319,780 shares. 4 times new highs have been achieved over the past 5 days, with a $3.70 gain in that time frame. In the last twenty days, the average volume was 589,750, while in the previous 50 days, it was 480,836.

Since last month, AMED stock retreated -10.46%. Shares of the company fell to $83.00 on 11/07/22, the lowest level in the past month. A 52-week high of $179.91 was reached on 03/29/22 after having rallying from a 52-week low of $83.00. Since the beginning of this year, AMED’s stock price has dropped by -43.63% or -$70.63, and marked a new high 3 times. However, the stock has declined by -49.28% since its 52-week high.

China Can't Stop US$0.25 Stock from Mining Ultra-Rare Metal

Here's one little-known company — trading undiscovered below 25-cents per share — that's advancing one of the largest and highest quality REE deposits in all of North America... and the Chinese can't do a damn thing about it! It's early stage... and that's excellent news for individual investors like you who have the foresight to act decisively on an emerging megatrend that's already being measured in the Tens of $Billions.

Simply click here and the name & trading symbol are yours.


AMED stock investors should be aware that Amedisys Inc. (AMED) stock had its last reported insider trading activity 154 days ago on Jun 23. Bohnert Denise M., the Chief Compliance Officer of the company, disposed of 557 shares for $115.00 on Jun 23. It resulted in a $64,055 divestment by the insider. Kemmerly David L sold 2,500 shares at an average price of $177.31 on Mar 29. The insider now owns 16,336 shares following the transaction. On Nov 30, Director LECHLEITER RICHARD A bought 1,000 shares at $141.25 apiece. The transaction was valued at $141,250.

Valuation Metrics

Right now, Amedisys Inc. (AMED) has a P/E ratio of about 24.70. The stock’s beta is 0.97. Besides these, the trailing price-to-sales (P/S) ratio of 1.32, the price-to-book (PB) ratio of 2.92, and the price-to-cash flow ratio of 31.73 may also be considered.

Financial Health

In the three months ended September 29, Amedisys Inc.’s quick ratio stood at 1.10, while its current ratio was 1.10, showing that the company is able to pay off its debt. According to company report, the long-term debt-to-equity ratio for the quarter ending September 29 was 0.44, and the total debt-to-equity ratio was 0.45. On the profitability front, the trailing twelve-month gross margin is 44.50% percent. In the year ended September 29, operating margins totaled 8.20%. Based on annual data, AMED earned $994.06 million in gross profit and brought in $2.23 billion in revenue.

A company’s management is another factor that investors consider when determining the profitability of an investment. In the past year, return on investment (ROI) was 15.50%. Return on equity (ROE) for the past 12 months was 12.40%.

In Amedisys Inc.’s quarter-end financial report for September 29, it reported total debt of $443.43 million. According to the earnings report, the company had a higher net income in the recent quarter than it did in the previous quarter. AMED’s revenue rose 0.81% to $557.89 million during the quarter, while net income inched up to $557.99 million. While analysts expected Amedisys Inc. to report $1.22 quarterly earnings, the actual figure was $1.15 per share, beating the consensus estimate by -5.70%. During the quarter, the company generated $56.98 million in EBITDA. The liabilities of Amedisys Inc. were 912.52 million at the end of its most recent quarter ended September 29, and its total debt was $561.96 million. The value of shareholders’ equity is $32.49 million.

Technical Picture

This quick technical analysis looks at Amedisys Inc.’s (AMED) price momentum. With a historical volatility rate of 45.86%, the RSI 9-day stood at 55.25% on 23 November.

With respect to its five-day moving average, the current Amedisys Inc. price is up by +4.23% percent or $3.70. At present, AMED shares trade -13.38% below its 20-day simple moving average and -20.91% percent below its 100-day simple moving average. However, the stock is currently trading approximately -22.90% below its SMA50 and -32.45% below its SMA200.

Stochastic coefficient K was 49.28% and Stochastic coefficient D was 31.09%, while ATR was 3.83. Given the Stochastic reading of 79.09% for the 14-day period, the RSI (14) reading has been calculated as 49.41%. As of today, the MACD Oscillator reading stands at -0.07, while the 14-day reading stands at 0.78.

Analyst Ratings

Amedisys Inc. downgraded its rating on Amedisys Inc. (NASDAQ: AMED) to a Mkt perform in a note to investors on October 27, 2022. The analysts firm previously had an Outperform rating on the stock.Amedisys Inc. (AMED) has been rated Overweight by analysts. According to 1 brokerage firm, AMED is a sell, and 5 firms recommend it is a Hold. There are 1 analyst who say the stock is underweight. A total of 0 analysts rate Amedisys Inc. stock as buy, with 8 recommending it as overweight.

With a median target price of $120.00, the current consensus forecast for the stock is $88.00 – $145.00. Based on these forecasts, analysts predict Amedisys Inc. (AMED) will achieve an average price target of $118.00.


Please enter your comment!
Please enter your name here